Advertisement
YOU ARE HERE: LAT HomeCollectionsSummit Technology Inc
IN THE NEWS

Summit Technology Inc

FEATURED ARTICLES
BUSINESS
September 17, 1993
Allergan Inc., a maker of skin- and eye-care products, said Thursday it has an agreement with Summit Technology Inc. to jointly promote a laser system and other products to eye specialists. Summit, based in Waltham, Mass., makes a laser used to treat eye problems such as nearsightedness and farsightedness.
ARTICLES BY DATE
BUSINESS
October 22, 1999
* Summit Technology Inc., which makes surgical lasers, said it won Food and Drug Administration approval for use of its laser in the treatment of nearsightedness. Summit is the No. 2 maker of eye surgery lasers; its shares rose $1.19 to close at $17.94 on Nasdaq. Shares of market leader Visx Inc. fell $1.75 to close at $71.69, also on Nasdaq.
Advertisement
BUSINESS
October 22, 1999
* Summit Technology Inc., which makes surgical lasers, said it won Food and Drug Administration approval for use of its laser in the treatment of nearsightedness. Summit is the No. 2 maker of eye surgery lasers; its shares rose $1.19 to close at $17.94 on Nasdaq. Shares of market leader Visx Inc. fell $1.75 to close at $71.69, also on Nasdaq.
BUSINESS
September 17, 1993
Allergan Inc., a maker of skin- and eye-care products, said Thursday it has an agreement with Summit Technology Inc. to jointly promote a laser system and other products to eye specialists. Summit, based in Waltham, Mass., makes a laser used to treat eye problems such as nearsightedness and farsightedness.
BUSINESS
May 25, 1993
Allergan Inc., a provider of eye-care and other medical products, said it has agreed to conduct joint clinical trials of drugs with Summit Technology Inc. The companies will conduct joint clinical trials of certain drugs for use after a surgical procedure known as photorefractive keratectomy. The procedure involves the use of a laser to correct eye disorders such as nearsightedness, farsightedness and astigmatism.
NEWS
March 14, 1995 | From Times Staff and Wire Reports
The Food and Drug Administration has approved an eye laser that polishes the cornea to improve vision and prevent the need for many corneal transplants. Summit Technology Inc. announced the approval of the nation's first excimer laser to treat corneal scars and other diseases. Experts predicted it could be used to treat between 10,000 and 25,000 Americans this year. Dr. Carmen A.
BUSINESS
February 25, 2000 | Bloomberg News
Bausch & Lomb Inc. said its eye laser won Food and Drug Administration approval, clearing the way for the company to enter the laser vision-correction market. Rochester, N.Y.-based Bausch & Lomb is the newest entry in a market in which growth has slowed and industry leaders are cutting prices. Visx Corp., the leading maker of eye lasers, and No. 2 Summit Technology Inc. this week announced a 60% reduction in the fees they charge doctors for each use of their lasers.
BUSINESS
June 9, 1998 | Bloomberg News
Visx Inc. said it will pay Summit Technology Inc. $35 million as the medical-laser companies settle lawsuits against each other and end their partnership. Santa Clara-based Visx and Summit, of Waltham, Mass., make lasers used to treat eye problems such as nearsightedness and farsightedness. Under their 1992 agreement, they were paying into a partnership and sharing revenue from eye operations using their lasers. The settlement ends months of legal wrangling over royalty payments.
BUSINESS
February 11, 1997 | Times Staff and Wire Reports
The $108-billion California Public Employees' Retirement System released its top 10 list of corporate America's financial underperformers. Apple Computer Inc. and Reebok International Ltd. head this year's list of companies that CalPERS will target for severe underperformance relative to their industry peers. The companies will serve as the focus of CalPERS' corporate governance activism for the 1997 proxy season. The other companies on its list are technology companies Novell Inc.
BUSINESS
May 25, 1993
Allergan Inc., a provider of eye-care and other medical products, said it has agreed to conduct joint clinical trials of drugs with Summit Technology Inc. The companies will conduct joint clinical trials of certain drugs for use after a surgical procedure known as photorefractive keratectomy. The procedure involves the use of a laser to correct eye disorders such as nearsightedness, farsightedness and astigmatism.
BUSINESS
March 25, 1998 | Reuters
Federal regulators voted unanimously to bring price-fixing charges against two makers of laser equipment to correct vision disorders, saying the scheme cost consumers $30 million a year in higher prices. The Federal Trade Commission voted 5 to 0 to bring the charges against Visx Inc. of Santa Clara and Summit Technology Inc. of Waltham, Mass., accusing them of improperly sharing fees charged to doctors who used equipment made by either company.
Los Angeles Times Articles
|